2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Update on HCC: Does Treatment With a Single, Priming Dose of Tremelimumab + Durvalumab Achieve Longest Median Survival in aHCC?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Daniel Lin
By 2020 ASCO Virtual Direct™ Highlights FEATURING Daniel Lin
143 views
August 6, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
GI
10:35
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on mCRC: Is T-DXd a New Treatment Option for Patien…

Feat. A. Loaiza-Bonilla
09:35
2020 ASCO Virtual Direct™ Highlights

2020 Update on Esophagogastric Cancers: Did T-DXd Demonstrate Meanin…

Feat. D. Lin
05:00
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Pancreatic Cancer: Perioperative Chemotherapy + …

Feat. D. Lin
09:51
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HCC: Does Treatment With a Single, Priming Dose …

Feat. D. Lin
12:28
2020 ASCO Virtual Direct™ Highlights

2020 ASCO mRCC Highlights: Does the Updated KEYNOTE-426 Analysis Sup…

Feat. M. Bupathi